Oral misoprostol does not hasten oviductal transport of day-5 horse embryos.

The study explores the impact of oral misoprostol on oviductal transport of horse embryos. It concludes that the substance does not expedite this process.

Introduction to the Study

• The research is centered on the proposition that the administration of the drug misoprostol might expedite the oviductal transport of horse embryos.
• This is based on the knowledge that prostaglandin E (PGE) – produced by embryos around Day 5 post ovulation in horses – directly affects the oviduct, promoting embryo transport into the uterus.
• Usually, the collection of horse embryos for cryopreservation is recommended at around Day 6.5 to 7 post-ovulation, which raised the hypothesis that the administration of misoprostol might be able to speed up this transfer process.

Research Methodology

• Two experiments were conducted to investigate the effect of oral misoprostol on the transport of horse embryos.
• In Experiment 1, a group of 15 horse embryos were administered with misoprostol on the 5th and 5.5th day post-ovulation and the time of embryo recovery was compared to that of a control group.
• In Experiment 2, misoprostol was introduced to a group of 16 embryos on Day 4.5; there was an initial attempt at embryo collection at Day 5.5, followed by additional attempts on Days 6 and 6.5 if no embryo was gathered earlier.
• Throughout both experiments, blood samples were collected at 12-hour intervals from Day 4.5 or 5, to Day 6.5 to monitor changes.

Study Findings

• In both experiments, administering misoprostol did not significantly chage the timing of the oviductal transport of horse embryos.
• In the first experiment, all embryos were collected by Day 6.5, whereas in the Second experiment, embryo collection spread across Day 5.5 through 6.5, regardless of when misoprostol was administered.
• The results also indicated that serum progesterone concentrations remained roughly the same, implying that the progesterone level isn’t influenced by the administration of misoprostol.

Conclusion

• The research found no evidence to support the hypothesis that misoprostol administration accelerates oviductal transport of horse embryos.
• The results held true regardless of the exact time at which misoprostol was administered during the ovarian cycle.